Abstract
We know more today about the safety of oral contraceptives (OC) than about any other medication. Because millions of healthy women use OC for extended lengths of time, the health effects become an important public health concern. After three decades of extensive study, investigators have demonstrated that OC, when given to healthy women, protect against unwanted pregnancy and its complications, improve health, and may even prolong life (1–5).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Vessey MP (1990) The Jephcott Lecture, 1989: An overview of the benefits and risks of combined oral contraceptives. In Mann RD (ed): Oral contraceptives and breast cancer. Carnforth, England, The Parthenon Publishing Group, pp. 121–136.
Pettiti DB (1994) Safety of birth control pills. In Samuels SE, Smith MD (eds): The pill: From prescription to over the counter. Menlo Park, The Henry J. Kaiser Family Fdn, pp. 77–115.
Harlap S, Kost K, Forrest JD (1991) Preventing pregnancy, protecting health. A new look at birth control choices in the United States. New York, The Alan Guttmacher Institute.
Fortney JA, Harper JM, Potts M (1986) Oral contraceptives and life expectancy. Stud Fam Plann 17:117–125.
Grimes DA (1992) The safety of oral contraceptives: Epidemiologic insights from the first 30 years. Am J Obstet Gynecol 166:1950–1954.
Grimes DA (1990) Breast cancer, the pill and the press. In: Oral contraceptives and breast cancer, Mann RD (ed), Carnforth, England, The Parthenon Publishing Group, 309–322.
The Gallup Organization (1994) Women’s attitudes toward oral contraceptives and other forms of birth control. Princeton, New Jersey, The Gallup Organization.
Prentice RL, Thomas DB (1987) On the epidemiology of oral contraceptives and disease. Adv Cancer Res 49:285–401.
Romieu I, Berlin JA, Colditz G (1990) Oral contraceptives and breast cancer: Review and meta-analysis. Cancer 66:2253–2263.
United Kingdom National Case-Control Study Group (1989) Oral contraceptive use and breast cancer risk in young women. Lancet 1:973–982.
Wingo PA, Lee NC, Ory HW, et al. (1991) Age-specific differences in the relationship between oral contraceptive use and breast cancer. Obstet Gynecol 78:161–170.
Beral V, Hannaford P, Kay C (1988) Oral contraceptive use and malignancies of the genital tract: Results from the Royal College of General Practitioners’ Oral Contraception Study. Lancet 2:1331–1335.
Vessey MP, Smith MA, Yeates D (1986) Return of fertility after discontinuation of oral contraceptives: Influence of age and parity. Brit J Fam Plan 11:120–124.
Bracken MB, Hellenbrand KG, Holford TR (1990) Conception delay after oral contraceptive use: The effect of estrogen dose. Fertil Steril 53:21–27.
Croft P, Hannaford PC (1989) Risk factors for acute myocardial infarction in women: Evidence frpm the Royal College of General Practitioners’ Oral Contraception Study. Brit Med J 298:165–168.
Engel HJ, Engel E, Lichtlen PR (1983) Coronary atherosclerosis and myocardial infarction in young women—Role of oral contraceptives. Eur Heart J 4:1–6.
Adams MR, Clarkson TB, Koritnik DR, Nash HA (1987) Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques. Fertil Steril 47:1010–1018.
Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development (1987) The reduction in risk of ovarian cancer associated with oral-contraceptive use. New Engl J Med 316:650–655.
Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development (1987) Combination oral contraceptive use and the risk of endometrial cancer. JAMA 257:796–800.
Grimes DA, Godwin AJ, Rubin A et al (1994) Ovulation and follicular development associated with three low dose oral contraceptives: A randomized controlled trial. Obstet Gynecol 83:29–34.
Caillouette JC, Koehler AL (1987) Phasic contraceptive pills and functional ovarian cysts. Am J Obstet Gynecol 156:1538–1542.
Holt VL, Daling JR, McKnight B, et al. (1992) Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives. Obstet Gynecol 79:529–533.
Lanes SF, Birmann B, Walker AM, Singer S (1992) Oral contraceptive type and functional ovarian cysts. Am J Obstet Gynecol 166:956–961.
Recker RR, Davies M, Hinders SM, et al. (1992) Bone gain in young adult women. JAMA 268:2403–2408.
Ross RK, Pike MC, Vessey MP, et al. (1986) Risk factors for uterine fibroids: Reduced risk associated with oral contraceptives. Brit Med J 293:359–362.
Gray RH (1987) Toxic shock syndrome and oral contraception. Am J Obstet Gynecol 156:1038.
Spector TD, Hochberg MC (1990) The protective effect of the oral contraceptive pill on rheumatoid arthritis: An overview of the analytic epidemiological studies using meta-analysis. J Clin Epidemiol 43:1221–1230.
Henderson BE, Ross RK, Pike MC (1993) Hormonal chemoprevention of cancer in women. Science 259:633–638.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag New York, Inc.
About this paper
Cite this paper
Grimes, D.A. (1996). Risks and Benefits of Oral Contraceptives. In: Li, J.J., Li, S.A., Gustafsson, JÅ., Nandi, S., Sekely, L.I. (eds) Hormonal Carcinogenesis II. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2332-0_36
Download citation
DOI: https://doi.org/10.1007/978-1-4612-2332-0_36
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7506-0
Online ISBN: 978-1-4612-2332-0
eBook Packages: Springer Book Archive